Staggering Results Show HIV-Transmission Reduced 100% with Twice-Yearly Lenacapavir Injection
A 2-stage trial testing a new and acclaimed HIV-prevention drug has shown almost unthinkable results of no new infections among a sample size of 3,200 participants. Called PURPOSE 1, the aim of the first trial was testing a subcutaneous injection of the drug Lenacapavir given twi
Jun 9, 2026Positivity +66
A 2-stage trial testing a new and acclaimed HIV-prevention drug has shown almost unthinkable results of no new infections among a sample size of 3,200 participants. Called PURPOSE 1, the aim of the first trial was testing a subcutaneous injection of the drug Lenacapavir given twi
This good news was originally reported by Good News Network. We curate and add context — they did the reporting.
Read the full story at the source →More good news
Armed With UK Degree, Bhopal Boy Aims to Power an Avocado Farming Revolution
The Better India · Jul 7, 2026